IWP
NVS icon

Icon Wealth Partners’s Novartis NVS Stock Holding History

Icon Wealth Partners’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$382K Sell
3,752
-108
-3% -$11K 0.04% 201
2023
Q2 		$390K Sell
3,860
-259
-6% -$25.9K 0.04% 223
2023
Q1 		$379K Buy
+4,119
New +$360K 0.04% 224
2022
Q2 		$463K Buy
5,477
+41
+0.8% +$3.6K 0.06% 194
2022
Q1 		$477K Buy
5,436
+598
+12% +$51.8K 0.05% 217
2021
Q4 		$423K Sell
4,838
-235
-5% -$19.5K 0.04% 224
2021
Q3 		$415K Buy
5,073
+146
+3% +$13.1K 0.04% 240
2021
Q2 		$450K Buy
4,927
+224
+5% +$19.9K 0.05% 233
2021
Q1 		$402K Sell
4,703
-3,258
-41% -$292K 0.05% 234
2020
Q4 		$752K Buy
7,961
+1,997
+33% +$175K 0.12% 138
2020
Q3 		$519K Buy
5,964
+379
+7% +$32.8K 0.1% 140
2020
Q2 		$488K Buy
5,585
+148
+3% +$12.8K 0.12% 129
2020
Q1 		$448K Buy
5,437
+1,264
+30% +$113K 0.18% 65
2019
Q4 		$395K Buy
4,173
+537
+15% +$48.2K 0.13% 87
2019
Q3 		$316K Sell
3,636
-252
-6% -$22.6K 0.11% 111
2019
Q2 		$355K Buy
3,888
+426
+12% +$36.1K 0.13% 96
2019
Q1 		$298K Sell
3,462
-132
-4% -$10.6K 0.11% 113
2018
Q4 		$276K Sell
3,594
-117
-3% -$9.11K 0.13% 109
2018
Q3 		$286K Sell
3,711
-67
-2% -$4.95K 0.12% 136
2018
Q2 		$256K Buy
3,778
+24
+0.6% +$1.66K 0.11% 134
2018
Q1 		$272K Sell
3,754
-1,872
-33% -$143K 0.15% 141
2017
Q4 		$423K Buy
+5,626
New +$424K 0.21% 98

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Icon Wealth Partners's NVS Position: Q3 2023 in Review

Icon Wealth Partners reduced its Novartis (NVS) stake by 2.8% in Q3 2023, selling an estimated $11K and leaving 3,752 shares worth $382K. The position accounts for 0.04% of the portfolio, ranked #201.

Icon Wealth Partners first reported a position in NVS in Q4 2017 and has held it in 22 quarters since. The position peaked at $752K in Q4 2020. 1,223 funds tracked by Wall St. Rank hold NVS as of Q3 2023.

  • Icon Wealth Partners held 3,752 shares of Novartis worth $382K as of Q3 2023.
  • Icon Wealth Partners sold 108 Novartis shares in Q3 2023, an estimated $11K.
  • Novartis made up 0.04% of Icon Wealth Partners's portfolio in Q3 2023, its #201 holding.
  • Icon Wealth Partners first reported a position in Novartis in Q4 2017 and has held it in 22 quarters since.
  • Icon Wealth Partners's Novartis position peaked at $752K in Q4 2020.
  • 1,223 funds tracked by Wall St. Rank held Novartis as of Q3 2023.

Based on Icon Wealth Partners's 13F filing for Q3 2023, filed 14 Nov 2023.